Promising Outcomes from Recent Experimental Kidney Cancer Vaccines
Introduction An experimental vaccine for advanced kidney cancer recently demonstrated success during its first phase of testing. Patients with advanced forms of the disease may find hope with these findings. The vaccine, developed by Dana-Farber Cancer Institute, Harvard Medical School, and Yale Cancer Center, aims to enhance the immune response to leftover cancer cells post-surgery…